Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (Remission Induction by Remicade in RA) study - Commentary

Tom Huizinga*, Peter Nigrovic, Eric Ruderman, Hendrik Schulze-Koops

*Corresponding author for this work

Research output: Contribution to journalComment/debatepeer-review

Fingerprint Dive into the research topics of 'Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (Remission Induction by Remicade in RA) study - Commentary'. Together they form a unique fingerprint.